Creatine for the treatment of depression

Kious, Kondo & Renshaw (2019) · Biomolecules

Topics: Mood & Mental Health, Brain & Cognition

  • Study type: Narrative review
  • Population: Adults with depressive disorders
  • Dose: 3-5 g/day (studied up to 10 g)
  • Duration: Weeks to months
  • Published: 2019

What the study found

This review examines the growing evidence that creatine, by supporting brain energy metabolism, may augment antidepressant treatment. Effects appear most promising in women and when added to standard therapy, though larger trials are still needed.

Key findings

  • Brain energy deficits are implicated in depression; creatine targets that system.
  • Adjunctive creatine sped and improved antidepressant response in some trials, especially in women.
  • Evidence is promising but not yet definitive — more RCTs required.

The practical takeaway

Creatine is an intriguing, low-cost adjunct for mood research — but it's not a replacement for professional mental-health care.

View the original study on PubMed